CD4-positive T-helper cell responses to the PASD1 protein in patients with diffuse large B-cell lymphoma

Abstract

This is the first report of a CD4-positive T-helper response to the PASD1 protein in patients with lymphoma. The immunogenic peptides described here represent valuable additional candidates for inclusion in a vaccine to treat patients with PASD1-positive diffuse large B-cell lymphoma whose disease is refractory to conventional therapies.